Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
Chen‐Hua Liu, Po-Yueh Chen, Jyh-Jou Chen, Gin‐Ho Lo, Wei‐Wen Su, Kuo‐Chih Tseng, Chun‐Jen Liu, Chia-Sheng Huang, Ke-Jhang Huang, Sheng‐Shun Yang, Cheng‐Yuan Peng, Ming‐Chang Tsai, Wei‐Yu Kao, Chi-Yang Chang, Yu‐Lueng Shih, Yu-Jen Fang, Chi-Yi Chen, Pei-Lun Lee, Jow-Jyh Huang, Pei–Yuan Su, Chi-Wei Tseng, Chien‐Ching Hung, Chung-Hsin Chang, Yi-Jie Huang, Hsueh‐Chou Lai, Chun‐Chao Chang, Fu-Jen Lee, Tsai‐Yuan Hsieh, Jia‐Horng Kao
Topics & Concepts
MedicineInternal medicineSofosbuvirHepatologyAdverse effectLiver diseaseGastroenterologyNauseaHepatitis C virusChronic liver diseaseHepatitis CSurgeryRibavirinCirrhosisVirusImmunologyHepatitis C virus researchHIV/AIDS drug development and treatmentLiver Diseases and Immunity